Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
Abstract Background The intestinal microbiota is thought to be involved in the occurrence of inflammatory bowel disease in remission with irritable bowel syndrome (IBS)-type symptoms, but the specific distinct profile of these bacteria remains unclear. This cross-sectional study aims to investigate...
Guardado en:
Autores principales: | Xiufang Cui, Haiyang Wang, Ziping Ye, Yi Li, Xinyun Qiu, Hongjie Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a37b7c8969fa4b83ad66a48369b296c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevalence, clinical characteristics, and management of irritable bowel syndrome in Vietnam: A scoping review
por: Duc Trong Quach, et al.
Publicado: (2021) -
Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study
por: Gwen M. C. Masclee, et al.
Publicado: (2021) -
Screening for Celiac Disease in Patients with Irritable Bowel Syndrome Fulfilling Rome III Criteria
por: Khaldoon Thanoon Al-Abachi
Publicado: (2021) -
The role of inflammation in irritable bowel syndrome (IBS)
por: Ng QX, et al.
Publicado: (2018) -
The challenges of implementing evidence‐based therapy for irritable bowel syndrome in Asia
por: Kee‐Huat Chuah, et al.
Publicado: (2021)